We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CytoReason

News List

CytoReason and Pfizer Extend Collaboration to Leverage Machine Learning in Drug Development AmericanPharmaceuticalReview
February 15, 2022
CytoReason announced the extension of its collaboration agreement with Pfizer.
CytoReason Collaborates with Sanofi, Using its AI Technology to Gain Better Understanding of Disease Mechanisms firstwordpharma
June 18, 2021
CytoReason today announced the initiation of a project with French global biopharmaceutical company Sanofi, which will utilize its cell-centered models and deconvolution techniques to suggest mechanistic insights for each asthma endotype.
Pfizer partners with CytoReason on immune system models for drug discovery pharmaceutical-technology
January 09, 2019
Israeli-machine learning company CytoReason has announced it has signed a collaboration agreement with Pfizer in which the latter will leverage the former’s technology to create cell-based models of the immune system.....
CytoReason uses artificial intelligence to personalise drug treatments expressbpd
March 26, 2018
Cytoreason uncovers a unique biomarker that can predict who will respond and who will not to anti TNF drugs helping thousands of patients gain proper treatment